300 related articles for article (PubMed ID: 28818014)
1. Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.
Becker JA; Berg KD; Røder MA; Brasso K; Iversen P
Scand J Urol; 2018 Feb; 52(1):1-7. PubMed ID: 28818014
[TBL] [Abstract][Full Text] [Related]
2. [Cytoreductive, radical prostatectomy in metastatic prostate cancer].
Chaloupka M; Herlemann A; Spek A; Gratzke C; Stief C
Urologe A; 2017 Nov; 56(11):1430-1434. PubMed ID: 28983651
[TBL] [Abstract][Full Text] [Related]
3. [Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].
Heidenreich A; Pfister D; Brehmer B; Porres D
Urologe A; 2015 Jan; 54(1):14-21. PubMed ID: 25519996
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
Mathieu R; Korn SM; Bensalah K; Kramer G; Shariat SF
World J Urol; 2017 Apr; 35(4):567-577. PubMed ID: 27502935
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Preisser F; Mazzone E; Nazzani S; Bandini M; Tian Z; Marchioni M; Steuber T; Saad F; Montorsi F; Shariat SF; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol; 2018 Dec; 74(6):693-696. PubMed ID: 30037529
[TBL] [Abstract][Full Text] [Related]
7. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
8. Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
Steuber T; Berg KD; Røder MA; Brasso K; Iversen P; Huland H; Tiebel A; Schlomm T; Haese A; Salomon G; Budäus L; Tilki D; Heinzer H; Graefen M; Mandel P
Eur Urol Focus; 2017 Dec; 3(6):646-649. PubMed ID: 28753877
[TBL] [Abstract][Full Text] [Related]
9. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
[TBL] [Abstract][Full Text] [Related]
10. Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes.
Costa WH; Guimarães GC
Int Braz J Urol; 2016; 42(5):876-879. PubMed ID: 27716456
[No Abstract] [Full Text] [Related]
11. Cytoreductive surgery in patients with oligometastatic prostate cancer. Systematic review of the scientific literature.
Ruiz Aragón J; Jiménez Varo E; Ruiz Aragón AI; Revelo Cadena I; Agüera Sánchez Á; Jiménez Romero ME
Actas Urol Esp (Engl Ed); 2023; 47(6):332-340. PubMed ID: 36319558
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive prostatectomy: what is the evidence? A systematic review.
Albisinni S; Aoun F; Diamand R; Al-Hajj Obeid W; Porpiglia F; Roumeguère T; De Nunzio C
Minerva Urol Nefrol; 2019 Feb; 71(1):1-8. PubMed ID: 30547907
[TBL] [Abstract][Full Text] [Related]
13. The cytoreductive radical prostatectomy in metastatic prostate cancer.
Vladimír Š; Zuzana S; Hana Š
Klin Onkol; 2022; 35(1):55-62. PubMed ID: 35236082
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive treatment strategies for de novo metastatic prostate cancer.
Connor MJ; Shah TT; Horan G; Bevan CL; Winkler M; Ahmed HU
Nat Rev Clin Oncol; 2020 Mar; 17(3):168-182. PubMed ID: 31712648
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports.
Rajwa P; Zattoni F; Maggi M; Marra G; Kroyer P; Shariat SF; Briganti A; Montorsi F; Heidegger I; Gandaglia G;
Eur Urol Focus; 2023 Jul; 9(4):637-641. PubMed ID: 36697321
[TBL] [Abstract][Full Text] [Related]
16. Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No.
Ristau BT; Smaldone MC
Int Braz J Urol; 2016; 42(5):880-882. PubMed ID: 27716457
[No Abstract] [Full Text] [Related]
17. Re: The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry.
Trelles CR; Martinez-Piñeiro L
Eur Urol; 2021 Dec; 80(6):764-765. PubMed ID: 34579999
[No Abstract] [Full Text] [Related]
18. Words of wisdom. Re: Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases--results of a feasibility and case-control study.
Satkunasivam R; Aron M
Eur Urol; 2015 Mar; 67(3):589-90. PubMed ID: 25760411
[No Abstract] [Full Text] [Related]
19. Cytoreductive radical prostatectomy versus no local treatment in patients with metastatic prostate cancer.
González-Browne C; Díaz J; Pinto I; Sandoval C; Vidal Á; Altamirano-Villarroel J
Medwave; 2023 May; 23(4):. PubMed ID: 37233030
[TBL] [Abstract][Full Text] [Related]
20. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial.
Mandel PC; Huland H; Tiebel A; Haese A; Salomon G; Budäus L; Tilki D; Chun F; Heinzer H; Graefen M; Pantel K; Riethdorf S; Steuber T
Eur Urol Focus; 2021 Jan; 7(1):55-62. PubMed ID: 31178293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
